Having beaten analysts' expectations in each of the last five quarters, Boston Scientific (NYSE:BSX) will announce on Thursday whether the streak is alive or snapped.
Continue Reading Below
Analysts currently expect Boston Scientific to come in with earnings of 11 cents per share on revenues of $1.89 billion. Analyst estimates range from earnings per share to earnings per share. Over the past three months, the average estimate has moved up from 10 cents.
The stock price has not been doing very well lately. It fell 71 cents per share between May 10, 2012 and June 5, 2012 to close at $5.57. Looking at change over the last three months, April 25, 2012 and July 20, 2012, the stock price fell 77 cents (-12.5%), from $6.15 to $5.38.
Company Fundamental Trends
Analysts think investors should stand pat on Boston Scientific with 15 of 22 analysts rating it hold. Analyst sentiment has been waning recently, as the average rating has dropped slightly over the past three months.
Last Quarter's Results
In the first quarter, profit rose more than twofold to $113 million (8 cents a share) from $46 million (3 cents a share) the year earlier, exceeding analyst expectations. Revenue fell 3.1% to $1.87 billion from $1.93 billion.
Reporting Period: 2Q
Date of Release: Thursday, July 26, 2012 before market open
EPS: 11 cents
Revenue Estimate: $1.89 billion
(Company fundamentals by Xignite Financials. Earnings estimates provided by Zacks)